NovoCure (NVCR) Q2 2026 Earnings

Apr 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.62
-0.52
-0.41
-0.31

Details

Expected EPS
-0.512186
Actual EPS
-0.62
Surprise EPS
-0.11
Surprise Percent
-21.05%

Description

⁨NovoCure⁩ (⁦NVCR⁩) has reported earnings of ⁦-0.62⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts